Is Harte Hanks, Inc. (HHS) a Buy, Sell, or Hold?
NASDAQ : HHS
Harte Hanks, Inc. — News
$2.33 USD
$0.05 (2.19%)
- Volume
- 518
- Average Volume
- 8.93K
- Market Capitalization
- $17.29M
- P/E Ratio
- -16.63
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.32
- Year Low
- $2.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.49
| Source | Headline |
|---|---|
|
Harte Hanks Receives Lenovo Operational Excellence Award for Driving AI-Enabled CX Performance and Operational Scale for Motorola
Recognition highlights sustained KPI performance, AI-driven innovation, and long-standing global partnership CHELMSFORD, MA / ACCESS Newswire / June 16, 2026 / Harte Hanks (NASDAQ:HHS), a leading global experience company, today announced it has been honored with the Lenovo Supplier Conference Operational Excellence Award at Lenovo's recent Supplier Conference in Hefei, China. The award was presented by Deguo Liu, Corporate Vice President, International Services Support, in recognition of Harte Hanks' exceptional performance supporting Motorola's customer experience operations in Manila. accessnewswire.com - 2026-06-16 14:45:00 |
|
Tecsys Achieves FedRAMP "Agency Auth In Process" Designation with HHS Sponsorship
Tecsys Achieves FedRAMP "Agency Auth In Process" Designation with HHS Sponsorship PR Newswire MONTREAL, June 15, gurufocus.com - 2026-06-15 08:00:00 |
|
Tecsys Achieves FedRAMP "Agency Auth In Process" Designation with HHS Sponsorship
Milestone advances Elite™ Platform Toward Class C Certification MONTREAL, June 15, 2026 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain management company, today announced it has been officially designated as "Agency Auth In Process" on the FedRAMP Marketplace, following sponsorship by the U.S. Department of Health and Human Services (HHS). Once certification is complete, Tecsys expects to be among a select group of FedRAMP-certified supply chain platforms. prnewswire.com - 2026-06-15 07:00:00 |
|
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. gurufocus.com - 2026-05-19 08:00:00 |
|
Harte Hanks Reports First Quarter 2026 Results
Advances Sector-Aligned Growth Strategy While Maintaining Strong Balance Sheet and Positive EBITDA CHELMSFORD, MA / ACCESS Newswire / May 14, 2026 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company focused on bringing companies closer to customers for over 100 years, today announced financial results for the first quarter ended March 31, 2026. Despite revenue pressure in the first quarter, the Company continued to drive operational progress and secure strategic new business wins across key industries. accessnewswire.com - 2026-05-14 16:05:00 |
